Background-MicroRNAs (miRNAs) are a newly discovered endogenous class of small, noncoding RNAs that play important posttranscriptional regulatory roles by targeting messenger RNAs for cleavage or translational repression. Human embryonic stem cells are known to express miRNAs that are often undetectable in adult organs, and a growing body of evidence has implicated miRNAs as important arbiters of heart development and disease. Methods and Results-To better understand the transition between the human embryonic and cardiac "miRNA-omes," we report here the first miRNA profiling study of cardiomyocytes derived from human embryonic stem cells. Analyzing 711 unique miRNAs, we have identified several interesting miRNAs, including miR-1, -133, and -208, that have been previously reported to be involved in cardiac development and disease and that show surprising patterns of expression across our samples. We also identified novel miRNAs, such as miR-499, that are strongly associated with cardiac differentiation and that share many predicted targets with miR-208. Overexpression of miR-499 and -1 resulted in upregulation of important cardiac myosin heavy-chain genes in embryoid bodies; miR-499 overexpression also caused upregulation of the cardiac transcription factor MEF2C. Conclusions-Taken together, our data give significant insight into the regulatory networks that govern human embryonic stem cell differentiation and highlight the ability of miRNAs to perturb, and even control, the genes that are involved in cardiac specification of human embryonic stem cells. (Circ Cardiovasc Genet. 2010;3:426-435.)
H uman embryonic stem cell-derived cardiomyocytes (hESC-CMs) hold great promise for myocardial regeneration after infarction. A number of groups have reported successful transplantation of hESC-CMs into rodent models of myocardial infarction. [1] [2] [3] However, a significant obstacle still exists with consistent derivation of purified hESC-CM populations. To precisely drive differentiation of hESCs into cardiac cells, a more comprehensive understanding of the regulatory networks that are involved in this process is needed. hESC-CM transcriptional profiling has already been reported 2 ; however, no group has yet focused on the rapidly evolving field of micro-RNAs (miRNAs) and their expression profiles in hESC-CMs.
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miRNAs play important posttranscriptional regulatory roles by targeting messenger RNAs for cleavage or transla-tional repression. 4 Hundreds of human miRNAs have been discovered, and each is predicted to target tens or hundreds of different messenger RNAs. hESCs are known to express miRNAs that are often undetectable in adult organs, [5] [6] [7] and some of these miRNAs are believed to regulate ESC selfrenewal and differentiation. 8 A growing body of evidence has also implicated miRNAs in heart disease and development. 9 As examples, miRNAs- 21, -195 , and -208 have demonstrated roles in heart failure, hypertrophy, and response to stress, 10 -12 whereas miRNAs-1 and -133 are known to regulate cardiac development, differentiation, and some aspects of disease. [13] [14] [15] [16] Although previous studies have highlighted miRNA profiles of hESCs and embryoid bodies (EBs), 5, 6 to date the miRNA signature of hESC-CMs remains unknown.
To better understand the transition between the human embryonic and cardiac "miRNA-omes," we report here the miRNA profiles of hESC-CMs. Our results confirm the presence of a signature group of miRNAs that is upregulated in hESCs and whose expression is significantly altered during differentiation to a cardiac lineage. We also identify novel patterns of miRNA expression, as well as individual miRNAs such as miR-499, that suggest a central role for miRNAs in pluripotency, differentiation, and maintenance of the cardiac phenotype.
Materials and Methods

Culture of Undifferentiated hESCs
All studies used cells derived from the female H7 hESC line (Wicell, Madison, Wis) and were maintained in the undifferentiated state with mTeSR1 medium (StemCell Technologies, Vancouver, Canada).
Preparation of hESC-CMs
Before differentiation, hESCs were switched to a mouse embryonic fibroblast-conditioned medium. For these experiments, hESC-CMs were generated according to a method adapted from a previously reported protocol for efficient cardiogenesis. 3
Immunohistochemical Analysis
Undifferentiated hESCs and hESC-CMs were plated onto 8-chamber slides, fixed with acetone on ice for 20 minutes, and then stained for immunofluorescence with the appropriate antibodies. Microscopy was performed with a Zeiss Axiovert microscopy (Sutter Instruments, Houston, Tex).
Fluorescence-Activated Cell Sorting Analysis
Cultures were dissociated with 0.05% trypsin, permeabilized with methanol, and incubated with ␣-sarcomeric actinin (Sigma A7811) or an isotype control in 20% heat-inactivated goat serum with a rat anti-mouse Fc block. Samples were washed, incubated with the appropriate secondary antibody (0.5 g/10 6 cells), and incubated at room temperature for 15 minutes in the dark. Samples were washed with 4 mL phosphate-buffered saline and resuspended in 200 L 0.5% paraformaldehyde before analysis on a FACSCalibur machine.
Lentiviral Production and Generation of Stable miRNA؉hESC Lines
Functional experiments were performed with lenti-miR miRNA precursors and an miRZip anti-miR-499 miRNA construct (System Biosciences, Mountain View, Calif). All experiments were performed a minimum of 3 times. SIN lentivirus was prepared by transient transfection of 293T cells. hESCs were stably transduced with lenti-miR miRNA precursors or miRZip anti-miR-499 miRNA constructs at a multiplicity of infection of 10. For the miRNA overexpression studies, the infectivity was determined by green fluorescent protein (GFP) expression as analyzed on a FACScan (BD Biosciences, San Jose, Calif). The GFP-positive cell populations were isolated by fluorescence-activated cell sorting in a Vantage SE cell sorter (Becton Dickinson, San Jose, Calif) followed by plating on a feeder cell layer for long-term culturing.
EB Formation
hESC colonies were dispersed into cell aggregates containing Ϸ500 to 1000 cells by using 1 mg/mL collagenase IV. The cell aggregates were then suspension-cultured in ultra-low-attachment cell-culture dishes with hESC differentiation medium (without basic fibroblast growth factor): 80% Dulbecco's modified Eagle's medium/F12, 1 mmol/L L-glutamine, 0.1 mmol/L ␤-mercaptoethanol, 0.1 mN nonessential amino acids, and 20% knockout serum replacement. The culture medium was changed every 2 days, for a total of 6 days.
Cell Sample Collection and RNA Preparation
Using the miRNeasy mini kit (Qiagen Inc, Valencia, Calif), total RNA containing miRNAs was isolated separately from biological duplicates of H7 hESCs and H7 hESC-CMs for microarray profiling.
As a positive control, total RNA was isolated from left ventricular tissue derived from two 20-week-old human fetus hearts. As a negative control, total RNA was isolated from IMR90 fetal fibroblasts (American Type Culture Collection, Manassas, Va). We prepared a total of 8 distinct RNA samples for miRNA profiling. For EB experiments, total RNA was isolated from biological triplicates (each experiment repeated a minimum of 3 times) of H7 hESCs and H7 EBs (day 6). Total RNA concentration and purity were analyzed by spectrophotometry.
Reverse Transcription-Polymerase Chain Reaction Analysis of Embryonic and Cardiac-Specific Transcriptions
The expression of human embryonic cell markers OCT4, NANOG, and REX1 and of cardiac-specific markers ANF, MEF2C, and GATA4 was compared before and after hESC differentiation. 18S was used as a housekeeping gene control. The primer sets used in the amplification reaction are as follows: human OCT4 forward primer, 5Ј-GGAAGGTATTCAGCCAAACGACCA-3Ј; human OCT4 reverse primer, 5Ј-CTCACTCGGTTCTCGATACTGGTT-3Ј; human NANOG forward primer, 5Ј-ACCAGAACTGTGTTCTCTTCCACC-3Ј; human NANOG reverse primer, 5Ј-CCATTGCTATTCTTC-GGCCAGTTG-3Ј; human REX1 forward primer, 5Ј-GCGTAC-GCAAATTAAAGTCCAGA-3Ј; human REX1 reverse primer, 5Ј-ATCCTAAACAGCTCGCAGAAT-3Ј; human ANF forward primer, 5Ј-TAGGGACAGACTGCAAGAGG-3Ј; human ANF reverse primer, 5Ј-CGAGGAAGTCACCATCAAACCAC-3Ј; human GATA4 forward primer, 5Ј-TCAAATTGGGATTTTCCGGA-3Ј; human GATA4 reverse primer: 5Ј-GCACGTAGACTGGCGAGGA-3Ј; human 18S forward primer, 5Ј-ACACGGACAGGATTGACAGA-3Ј; and human 18S reverse primer, 5Ј-GGACATCTAAGGGCATCACAG-3Ј.
miRNA Microarray Construction, Hybridization, and Scanning
A microarray assay was performed by a service provider (LC Sciences, Houston, Tex). The assay started with 4 to 8 g total RNA sample, which was fractionated by size in a YM-100 Microcon centrifugal filter (Millipore, Billerica, Mass), and the small, isolated RNAs (Ͻ300 nucleotides) were 3Ј-extended with a poly(A) tail with poly(A) polymerase. An oligonucleotide tag was then ligated to the poly(A) tail for later fluorescent dye staining. Hybridization was performed overnight on a Paraflo microfluidic chip and a microcirculation pump (Atactic Technologies, Houston, Tex). 17 On the microfluidic chip, each detection probe consisted of a chemically modified nucleotide coding segment complementary to the target miRNA (from miRBase; http://microrna.sanger.ac.uk/sequences/) or other control RNA and a spacer segment of polyethylene glycol to extend the coding segment away from the substrate. The detection probes were made by in situ synthesis by photogenerated reagent chemistry. Hybridization included the use of 100 L of 6ϫ standard saline phosphate/EDTA buffer (0.90 mol/L NaCl, 60 mmol/L Na 2 HPO 4 , 6 mmol/L EDTA; pH 6.8) containing 25% formamide at 34°C. After RNA hybridization, tag-conjugating Cy3 or Cy5 dyes were circulated through the microfluidic chip for dye staining. Fluorescence images were collected by a laser scanner (GenePix 4000B, Molecular Devices, Sunnyvale, Calif) and digitized with Array-Pro image analysis software (Media Cybernetics, Bethesda, Md).
miRNA Profiling Data Analysis
The miRNA profiling data analysis is available in the online-only Data Supplement.
Real-Time Quantitative Polymerase Chain Reaction
For messenger RNA quantitative polymerase chain reaction (qPCR), 2 g of total RNA from each sample was reversed-transcribed with Superscript III (Invitrogen). For each sample, real-time qPCR was performed in triplicate on an ABI 7900HT instrument (Applied Biosystems) with Taqman primer probe sets (Applied Biosystems, Foster City, Calif) for each gene of interest and an 18S endogenous control primer probe set for normalization. Representative results are shown as fold expression relative to undifferentiated hESCs unless otherwise stated. Error bars reflect 1 standard deviation from the mean of 3 biological replicates unless otherwise stated. miRNA qPCR was performed by LC Sciences. In brief, singlestranded cDNA was synthesized from total RNA samples with the use of a TaqMan miRNA reverse transcription kit (Applied Biosystems) according to the manufacturer's instructions. cDNA was then PCR-amplified with use of the human TaqMan miRNA assay system (Applied Biosystems) for the following human miRNAs: miR-1, miR-302c, miR-302d, miR-133a, and miR-16. We included miR-16 because it has been reported to exhibit relatively stable expression across multiple tissue types. 18 Data were normalized to the endogenous control genes RNU48 and U47. 19 Results are shown as fold expression relative to undifferentiated hESCs unless otherwise noted. Error bars indicate 1 standard deviation from the mean of 3 technical replicates unless otherwise stated.
Western Blots
Cells were collected in RIPA lysis buffer and briefly sonicated to shear DNA and reduce sample viscosity. The protein concentration of the supernatant was determined by the Bio-Rad protein assay. Each sample supernatant in an equal volume of loading buffer was run on 12% Tris-glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and transferred to a Hybond ECL membrane (Amersham Biosciences, Upsalla, Sweden). Protein blots were analyzed with GATA4 (Abcam, Cambridge, UK) and MEF2C (Abcam) antibodies and developed by ECL assay (Amersham).
Electrophysiologic Characterization
Spontaneously beating clusters were microsurgically dissected from hESC-derived EBs 14 to 21 days after differentiation was initiated. After collagenase dissociation and plate attachment, electrophysiologic experiments of isolated, single hESC-CMs were performed with the whole-cell, patch-clamp technique with an Axopatch 200B amplifier and pClamp9.2 software (Axon Instruments Inc, Foster City, Calif). A xenon arc-lamp was used to view GFP fluorescence at 488 nm excitation/530 nm emission. Patch pipettes were prepared from 1.5-mm, thin-walled borosilicate glass tubes by using a Sutter P-97 micropipette puller and had typical resistances of 4 to 6 M⍀ when filled with an internal solution containing the following (in mmol/L): 110 potassium aspartate, 20 KCl, 1 MgCl 2 , 0.1 Na-GTP, 5 Mg-ATP, 5 Na 2 -phospocreatine, 1 EGTA, and 10 HEPES, with pH adjusted to 7.3 with KOH. The external Tyrode's bath solution consisted of the following (in mmol/L): 140 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES, with pH adjusted to 7.4 with NaOH. Current-clamp recordings were performed at 37°C within 4 to 7 days after the lenti-miR transduction.
Statistical Analysis
Non-microarray data are presented as meanϮSD. Data were compared by standard or repeated measures, with ANOVA where appropriate. Pairwise comparisons were performed with a 2-tailed Student t test. Differences were considered significant for PϽ0.05.
Results
To determine the miRNA-omes of hESC-CMs, CMs were differentiated from H7 hESCs according to a published protocol. 3 Flow cytometry revealed that Ͼ90% of cells were positive for the cardiac marker ␣-sarcomeric actinin ( Figure 1A ). hESC-CMs spontaneously beat in culture (online-only videos I-IV) and exhibited a musclelike morphology that was similar to that of isolated left ventricular human fetal heart cells ( Figure 1B ). Whereas hESCs stained positive for OCT4 ( Figure 1C ), hESC-CMs stained positive for the cardiacspecific markers troponin-T, MEF2C, and connexin 43 (Figure 1D ). Real-time PCR further revealed that hESC-CMs expressed cardiac genes NKX2.5, ANF, GATA4, ␣-myosin heavy chain (MHC) (MYH6), ␤MHC (MYH7), and ␤MHC7b (MYH7B), with a corresponding decrease in embryonic genes OCT4, NANOG, and REX1 ( Figure 1 , E and F). By qPCR, we noted similar, though not identical, gene expression levels in hESC-CMs compared with those in the fetal heart, suggesting that these cells are different from fetal heart cells, as has been previously described. 2 Next, we analyzed 711 unique miRNAs in hESC-CMs and human fetal left ventricles with the Sanger miRBase version 10.0 miRNA expression microarrays (LC Sciences). miRNA profiles for H7 hESCs and human fetal fibroblasts from our previous publication 20 were also included in the analysis. The expression levels of a select group of miRNAs were confirmed with qPCR (online-only Data Supplement Figure I ; see onlineonly Data Supplement Table I for the full normalized data set).
We first performed a principal-component analysis, a reductionist method that provides an overview of the degree of variation between samples (online-only Data Supplement Figure II ). Principal-component analysis indicated that the miRNA expression profile was distinct for each of the 4 sample groups, with fetal heart and hESC-CMs exhibiting the closest distance, and thus the most similar miRNA profiles, and hESCs the furthest from the other 3 groups. Using clustered heat maps of subsets of miRNAs, we organized miRNAs into 3 broad categories: miRNAs that were significantly expressed in hESCs (Figure 2A ) and similar to those in previous studies 5, 7 ; miRNAs significantly expressed in the cardiac phenotype (heart and hESC-CMs) ( Figure 2B) ; and miRNAs significantly expressed in fetal samples (heart and fibroblasts) (online-only Data Supplement Figure III ; see online-only Data Supplement Figure IV for complete heat maps). These miRNA subsets were further refined (Figure 2 , C through F). Some miRNAs increased during differentiation ( Figure 2D ) but were not cardiac-specific because they were also expressed in fibroblasts, whereas other miRNAs decreased during differentiation ( Figure 2E ). Of interest in this former group is miR-145, which has been previously reported to be upregulated during differentiation and is an inhibitor of OCT4, SOX2, and KLF4. 21 We were, of course, particularly interested in miRNAs that appeared to be cardiac-specific because these miRNAs may be critical for driving cardiac differentiation. Known cardiovascularly related miRNAs include miRNAs-1, -133, and -208, which have roles in heart failure, hypertrophy, stress response, cardiac and skeletal muscle development, and differentiation. 10,11,14 -16 In our profiles, these miRNAs showed robust expression in hESC-CMs and (with the exception of miR-208a) the fetal heart, but were nearly undetectable in hESCs and fibroblasts ( Figure 2F ). Interestingly, we observed coexpression of miRNAs and their host genes. 22 For example, miR-208a is transcribed from an intron of the MHC ␣MHC (MYH6, online-only Data Supplement Figure  V) , and its expression therefore follows that of ␣MHC: higher expression in hESC-CMs relative to fetal heart ( Figure 1F ). In contrast, miR-208b is transcribed from intronic regions of ␤MHC (MYH7), and its expression thus follows that of ␤MHC: mildly higher expression in the fetal heart compared with hESC-CMs (see online Table I for quantitative miRNA expression data).
Of the cardiac phenotype-associated miRNAs identified in Figure 2B , we observed 1 miRNA, miR-499-5p, that showed statistically significant expression in the cardiac phenotypes but was undetectable in hESCs and fibroblasts ( Figure 2F ), a pattern similar to that of miR-1, -133, and -208b. This miRNA has been previously reported to be important in human fetal CM differentiation 23 and regulation of murine muscle myofibers. 24 Like the miR-208 family, miR-499 is located in an intronic region of an MHC gene, ␤MHC7B
(online-only Data Supplement Figure V) , and its trend in expression follows that of ␤MHC7B: higher expression in the fetal heart compared with hESC-CMs. Using TargetScan (www.targetscan.org), an online database of predicted biological targets of miRNAs based on the presence of conserved 8-mer and 7-mer sites that match the seed region of each miRNA, we found that miR-499 shared many targets with miR-208 and had some overlap with miR-1 targets ( Figure 3A) . Canonical pathway analysis of the predicted targets for miR-499 according to the Ingenuity Pathways Analysis (Ingenuity Systems, www.ingenuity.com) revealed that many targeted genes are involved in early cardiogenesis (for example, the transcription factor GATA4 25 ) and embryogenesis. Targeted canonical pathways included Wnt/␤catenin signaling, 26 transforming growth factor-␤ signaling, and cell cycle regulation (see the Table for selected pathways  and online-only Data Supplement Table II for the complete data set). These findings suggest that miR-499 may be involved in maturation of CMs via inhibition of embryogenesis and cardiogenesis pathways.
Next, we wanted to know whether the predicted targets of miR-499, along with miR-1 and -208, were significantly downregulated during cardiac differentiation as these miRNAs became more highly expressed. For example, are the target genes of miR-499 downregulated in the fetal heart relative to hESCs owing to the higher expression of miR-499? Using microarray data from our previous study 2 (GEO accession number GSE13834), we used gene set enrichment analysis (GSEA) 27 to analyze the enrichment of predicted miRNA targets in 3 successive stages of cardiac differentiation relative to hESCs: beating EBs (an intermediate stage of cardiac differentiation), hESC-CMs, and fetal heart. In Figure 3B , the y axis represents the normalized enrichment score, which is the primary statistic for examining GSEA results. A normalized enrichment score Ͼ1 means that the targets are more highly expressed in the cardiac cell type, and a normalized enrichment score Ͻ1 means that the targets are more highly expressed in hESCs (see online-only Data Supplement Table III for quantitative data). As expected, a custom set of 26 genes that are each associated with pluripotency was more highly enriched in undifferentiated hESCs compared with the 3 cardiac differentiation stages. In contrast, the predicted targets of the miR-302 cluster, which was significantly upregulated in hESCs and has been previously associated with pluripotent cell types, 20 had the opposite pattern of expression: higher enrichment in the 3 stages of cardiac differentiation relative to hESCs, as expected for an "embryonic" miRNA. Importantly, the predicted target genes for miR-1, -208, and -499 each exhibited similar enrichment patterns wherein the target genes were gradually reduced in expression during cardiac The normalized enrichment score indicates the degree of gene set enrichment in the indicated cell type relative to hESCs: Ͼ1 defines upregulation; Ͻ1 defines downregulation. During cardiac differentiation, the gene targets of miR-1, -208, and -499 are increasingly less enriched (relative to hESCs) owing to higher expression of these miRNAs in cardiac cell types. In contrast, the targets of the hESC-specific miR-302 cluster are consistently highly enriched in all cell types relative to hESCs, whereas pluripotency genes are consistently less enriched, as expected. Gene sets were considered significant with a Q value Ͻ0.25 (see Materials and Methods). differentiation, thus underscoring the similarity of miR-499 with the better-characterized miR-1 and -208 miRNAs. We also performed GSEA in a mouse system with previously published microarray data for murine ESCs differentiating to CMs 28, 29 (GEO accession numbers GSE5671 and GSE10970). Similar to our results in human cells, we found that the predicted targets for miR-499, -1, and -208 became successively less enriched during cardiac differentiation (online-only Data Supplement Figure VI) .
We next wanted to determine how overexpression of miR-1 and -499 might affect cardiac gene expression in differentiating hESCs. Using lenti-miR miRNA precursor lentiviral constructs (System Biosciences, Mountain View, Calif; [online-only Data Supplement Figure VIIa] ), we stably transduced H7 hESCs with miR-1 or miR-499 ( Figure 4A ). qPCR confirmed upregulation of the 2 miRNAs (online-only Data Supplement Figure VIIb) . Cells were differentiated into EBs, and qPCR was then used to determine embryonic, mesodermal, and cardiac gene changes on day 6 ( Figure 4B ). Interestingly, we noted significant upregulation of MEF2C in miR-499 EBs relative to miR-1 EBs and WT EBs. MEF2C is required for activation of cardiac contractile genes and for cardiac structural development, 30 suggesting that miR-499 may be an important factor in differentiating hESCs. However, knockdown of miR-499 with an miRZip anti-miR-499 miRNA construct (System Biosciences) that specifically inhibits the Ϫ5p and not the Ϫ3p isoform did not downregulate MEF2C as expected, suggesting that other cardiogenic pathways may be involved that maintain MEF2C expression. We also observed upregulation of ␤MHC in miR-499 EBs relative to wild-type EBs. miR-1 EBs exhibited upregulation of all 3 MHC isoforms. Furthermore, GATA4 was significantly upregulated in miR-1 EBs but not in miR-499 EBs, suggesting that miR-1 and -499 each have distinct yet positive roles in CM biology.
Western blots confirmed higher protein expression of MEF2C in miR-499 EBs and GATA4 in miR-1 EBs relative to the other cell lines (online-only Data Supplement Figure  VIIc) . Clearly, these results highlight the ability of specific miRNAs, such as miR-499 and -1, to alter the expression of genes involved in the cardiac specification of hESCs.
Two studies have reported cardiac conduction abnormalities in murine hearts either after transfection with miR-1 31 or in mutants that lack miR-1 expression. 14 To further explore the functional effects of miR-1 and -499, we also transduced postdifferentiated hESC-CMs with each miRNA. miR-1 transduction statistically decreased the beating rates of spontaneously contracting EB clusters, although miR-499 had no effect (6 independent batches, PϽ0.05; Figure 5A ). Consistently, the pacemaker current, which is known to play a major role in phase 4 depolarization, decreased its amplitude with miR-1 overexpression ( Figure 5B ). This finding confirms a previous report in which miR-1 was shown to decrease the pacemaker current by targeting the pacemaker genes HCN2 and HCN4 in hypertrophic CMs. 32 
Discussion
In this study, we sought to generate a systems-level overview of the miRNA profiles in hESCs, hESC-CMs, and the human fetal heart. Our results indicate that these profiles are highly dynamic and specific during cardiac differentiation of hESCs. Several interesting miRNAs, including miR-1, -208, and -133, that have been previously reported to be important in cardiac development and disease, exhibited significant changes during cardiac differentiation. Other miRNAs such as miR-499 that have poorly defined roles in development and differentiation also showed cardiac-specific expression. GM indicates granulocyte-macrophage; CSF, colony-stimulating factor; BTG, B cell translocation gene; PPAR, peroxisome proliferator-activated receptor; RXR, retinoid X receptor; NFAT, nuclear factor of activated T-cells; ERK, extracellular regulated kinase; MAPK, mitogen-activated protein kinase; TGF, transforming growth factor; GABA, ␥-aminobutyric acid. Analysis was performed with the TargetScan database and Ingenuity Pathways Analysis software. In silico analysis of the predicted targets for selected miRNAs revealed significant overlap between miR-208 and -499, both of which are transcribed from the introns of MHCs.
Admittedly, the field of computational predictions of miRNA targets is still in its infancy, so we cannot assume complete confidence in their accuracy until further validation through functional assays is performed. However, the analysis of target gene sets by GSEA, rather than by individual genes, lends increased statistical power to the in silico analysis of target predictions. Using this algorithm, we have shown that miR-499 shares many similarities with previously identified cardiac-specific miRNAs in terms of gene targets and expression pattern. In general, the targets of miR-1, -208, and -499 exhibited very similar pattern of expression: high enrichment in EBs, moderate enrichment in hESC-CMs (although miR-1 targets were still highly expressed in hESC-CMs), and significantly reduced enrichment in the fetal heart. We were surprised by some of the continued target expression in hESC-CMs, which may be due to the heterogeneity of the hESC-CMs, potential biological differences between the hESC lines (H7 versus H9) used by this study and Cao et al, 2 and also the poorly understood roles these miRNAs play during cellular differentiation. This latter point is based on the observation that some miRNAs are coexpressed with their target mRNAs 33 and thus may represent complex, incoherent feedback loops 34 that help fine-tune the expression levels of important transcription factors.
Lastly, with the ultimate goal of discovering factors that might enhance cardiac differentiation, we selected miR-499 and -1 for functional studies. Each miRNA had significant, though different, positive effects on cardiac differentiation, suggesting a powerful role for miRNAs in influencing hESC fate decisions. What is likely necessary for the efficient differentiation of hESCs to CMs is the combinatorial expression of miR-1, miR-499, and others, such as miR-208, that together regulate that molecular programs of hESC-CMs. In the future, we believe miRNAs will play a key role in achieving higher yields of hESC-CMs that can then be used for transplantation studies and, ultimately, clinical therapies. 
